These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18230357)

  • 1. Use of the bioMérieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
    Apple FS; Smith SW; Pearce LA; Ler R; Murakami MM; Benoit MO; Levy C; Dumas C; Paul JL
    Clin Chim Acta; 2008 Apr; 390(1-2):72-5. PubMed ID: 18230357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
    Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay.
    Apple FS; Smith SW; Pearce LA; Murakami MM
    Clin Biochem; 2012 Jul; 45(10-11):711-3. PubMed ID: 22465126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
    Venge P; Johnston N; Lindahl B; James S
    J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
    Apple FS; Smith SW; Pearce LA; Ler R; Murakami MM
    Clin Chem; 2008 Apr; 54(4):723-8. PubMed ID: 18238833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept.
    Ilva T; Eriksson S; Lund J; Porela P; Mustonen H; Pettersson K; Pulkki K; Voipio-Pulkki LM
    Eur J Clin Invest; 2005 Feb; 35(2):112-6. PubMed ID: 15667582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of high sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series.
    Wu AH
    Clin Chim Acta; 2009 Mar; 401(1-2):170-4. PubMed ID: 19135041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic role of cardiac troponin I (cTnI) measured on the DPC Immulite.
    Collinson PO; Gaze DC; Stubbs PJ; Swinburn J; Khan M; Senior R; Lahiri A
    Clin Biochem; 2006 Jul; 39(7):692-6. PubMed ID: 16580659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
    Wilson SR; Sabatine MS; Braunwald E; Sloan S; Murphy SA; Morrow DA
    Am Heart J; 2009 Sep; 158(3):386-91. PubMed ID: 19699861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit.
    Apple FS; Chung AY; Kogut ME; Bubany S; Murakami MM
    Clin Chim Acta; 2006 Aug; 370(1-2):191-5. PubMed ID: 16545790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department.
    Amodio G; Antonelli G; Varraso L; Ruggieri V; Di Serio F
    Coron Artery Dis; 2007 May; 18(3):181-6. PubMed ID: 17429291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early markers of myocardial injury: cTnI is enough.
    Ilva T; Lund J; Porela P; Mustonen H; Voipio-Pulkki LM; Eriksson S; Pettersson K; Tanner P; Pulkki K
    Clin Chim Acta; 2009 Feb; 400(1-2):82-5. PubMed ID: 18992232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay.
    van de Kerkhof D; Peters B; Scharnhorst V
    Ann Clin Biochem; 2008 May; 45(Pt 3):316-7. PubMed ID: 18482922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome.
    Brunet P; Oddoze C; Paganelli F; Indreies M; Faure V; Opris-Saveanu A; Morange S; Portugal H; Dussol B; Berland Y
    Int J Cardiol; 2008 Sep; 129(2):205-9. PubMed ID: 17662483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values.
    Apple FS; Murakami MM; Quist HH; Pearce LA; Wieczorek S; Wu AH
    Am J Clin Pathol; 2003 Jul; 120(1):114-20. PubMed ID: 12866381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study.
    Macdonald SP; Nagree Y
    Emerg Med Australas; 2008 Oct; 20(5):403-9. PubMed ID: 18973637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.
    Apple FS; Pearce LA; Smith SW; Kaczmarek JM; Murakami MM
    Clin Chem; 2009 May; 55(5):930-7. PubMed ID: 19299542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction.
    Casals G; Filella X; Augé JM; Bedini JL
    Am J Clin Pathol; 2008 Dec; 130(6):964-8. PubMed ID: 19019775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N; Viswanathan K; Das R; Morrell C; Farrin A; Barth JH; Hall AS;
    J Am Coll Cardiol; 2007 Nov; 50(21):2061-7. PubMed ID: 18021874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction.
    Palamalai V; Murakami MM; Apple FS
    Clin Biochem; 2013 Nov; 46(16-17):1631-5. PubMed ID: 23850852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.